Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery

被引:3
作者
Li, Qingxin [1 ]
Kang, Congbao [2 ]
机构
[1] Guangdong Acad Sci, Inst Biol & Med Engn, Guangdong Prov Engn Lab Biomass High Value Utiliza, Guangzhou 510316, Peoples R China
[2] ASTAR, Expt Drug Dev Ctr EDDC, 10 Biopolis Rd,05-01, Singapore 138670, Singapore
关键词
F-19-NMR; fragment screening; drug discovery; fragment-based drug design; in-cell F-19-NMR; OBSERVED FLUORINE NMR; PROTEIN-PROTEIN INTERACTIONS; LIGAND BINDING; STD NMR; RNA; SPECTROSCOPY; IDENTIFICATION; TOOL; QUANTIFICATION; VALIDATION;
D O I
10.3390/molecules29235748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based drug discovery is a powerful approach in drug discovery, applicable to a wide range of targets. This method enables the discovery of potent compounds that can modulate target functions, starting from fragment compounds that bind weakly to the targets. While biochemical, biophysical, and cell-based assays are commonly used to identify fragments, F-19-NMR spectroscopy has emerged as a powerful tool for exploring interactions between biomolecules and ligands. Because fluorine atoms are not naturally present in biological systems, F-19-NMR serves as a sensitive method for fragment screening against diverse targets. Herein, we reviewed the applications of F-19-NMR in fragment screening, highlighting its effectiveness in identifying fragments that bind weakly to various targets such as proteins and RNA. The accumulated evidence suggests that F-19-NMR will continue to be a crucial tool in drug discovery.
引用
收藏
页数:16
相关论文
共 133 条
[1]   Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening [J].
Aretz, Jonas ;
Rademacher, Christoph .
FRONTIERS IN CHEMISTRY, 2019, 7
[2]   Allosteric Inhibition of a Mammalian Lectin [J].
Aretz, Jonas ;
Anumala, Upendra R. ;
Fuchsberger, Felix F. ;
Molavi, Narges ;
Ziebart, Nandor ;
Zhang, Hengxi ;
Nazare, Marc ;
Rademacher, Christoph .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (44) :14915-14925
[3]   Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery [J].
Arntson, Keith E. ;
Pomerantz, William C. K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (11) :5158-5171
[4]   Quantifying Siglec-sialylated ligand interactions: a versatile 19F-T2 CPMG filtered competitive NMR displacement assay [J].
Atxabal, Unai ;
Fernandez, Andrea ;
Moure, Maria Jesus ;
Sobczak, Klaudia ;
Nycholat, Corwin ;
Almeida-Marrero, Veronica ;
Oyenarte, Iker ;
Paulson, James C. ;
de la Escosura, Andres ;
Torres, Tomas ;
Reichardt, Niels C. ;
Jimenez-Barbero, Jesus ;
Ereno-Orbea, June .
CHEMICAL SCIENCE, 2024, 15 (27) :10612-10624
[5]   Practical Considerations and Guidelines for Spectral Referencing for Fluorine NMR Ligand Screening [J].
Ayotte, Yann ;
Woo, Simon ;
LaPlante, Steven R. .
ACS OMEGA, 2022, 7 (15) :13155-13163
[6]   Development of potent inhibitors by fragment-linking strategies [J].
Bedwell, Elizabeth, V ;
McCarthy, William J. ;
Coyne, Anthony G. ;
Abell, Chris .
CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (04) :469-486
[7]   NMR-based Fragment Screening in a Minimum Sample but Maximum Automation Mode [J].
Berg, Hannes ;
Martin, M. A. Wirtz ;
Niesteruk, A. ;
Richter, C. ;
Sreeramulu, S. ;
Schwalbe, H. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172)
[8]   19F NMR-Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter-Screens [J].
Binas, Oliver ;
de Jesus, Vanessa ;
Landgraf, Tom ;
Voelklein, Albrecht Eduard ;
Martins, Jason ;
Hymon, Daniel ;
Kaur Bains, Jasleen ;
Berg, Hannes ;
Biedenbaender, Thomas ;
Fuertig, Boris ;
Lakshmi Gande, Santosh ;
Niesteruk, Anna ;
Oxenfarth, Andreas ;
Shahin Qureshi, Nusrat ;
Schamber, Tatjana ;
Schnieders, Robbin ;
Troester, Alix ;
Wacker, Anna ;
Wirmer-Bartoschek, Julia ;
Wirtz Martin, Maria Alexandra ;
Stirnal, Elke ;
Azzaoui, Kamal ;
Richter, Christian ;
Sreeramulu, Sridhar ;
Jose Blommers, Marcel Jules ;
Schwalbe, Harald .
CHEMBIOCHEM, 2021, 22 (02) :423-433
[9]   Fluorine in medicinal chemistry [J].
Böhm, HJ ;
Banner, D ;
Bendels, S ;
Kansy, M ;
Kuhn, B ;
Müller, K ;
Obst-Sander, U ;
Stahl, M .
CHEMBIOCHEM, 2004, 5 (05) :637-643
[10]   Fragment-based drug discovery-the importance of high-quality molecule libraries [J].
Bon, Marta ;
Bilsland, Alan ;
Bower, Justin ;
McAulay, Kirsten .
MOLECULAR ONCOLOGY, 2022, 16 (21) :3761-3777